SCHEMBL3303640

SCHEMBL3303640

Cc1cc(-c2nc(-c3ccccn3)nc(-c3ccccn3)n2)ccc1-c1ccccc1-c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.49
TDP1 Q9NUW8 1/20 0.49
SMN1; SMN2 Q16637 6/20 0.44
RAB9A P51151 5/20 0.44
PKM P14618 5/20 0.44
NPC1 O15118 5/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
MITF O75030 2/20 0.44
GAA P10253 2/20 0.44
GRM5 P41594 4/20 0.43
TP53 P04637 4/20 0.43
LMNA P02545 4/20 0.43
TSHR P16473 3/20 0.43
MAPT P10636 2/20 0.43
HPGD P15428 2/20 0.43
HSD17B10 Q99714 2/20 0.43
ALDH1A1 P00352 1/20 0.43
KLF5 Q13887 1/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13154556 0.92 KDM4E (0.51) KDM4ETDP1SMN1; SMN2RAB9APKM
SCHEMBL21481228 0.89 KDM4E (0.55) KDM4ETDP1SMN1; SMN2RAB9APKM
SCHEMBL21485434 0.89 KDM4E (0.55) KDM4ETDP1SMN1; SMN2RAB9APKM
SCHEMBL21481292 0.87 KDM4E (0.56) KDM4ETDP1SMN1; SMN2RAB9APKM
SCHEMBL21481313 0.86 KDM4E (0.58) KDM4ETDP1SMN1; SMN2RAB9APKM
SCHEMBL24689430 0.85 KDM4E (0.62) KDM4ETDP1SMN1; SMN2RAB9APKM
SCHEMBL21481287 0.84 KDM4E (0.56) KDM4ETDP1SMN1; SMN2RAB9APKM
SCHEMBL21481310 0.84 KDM4E (0.56) KDM4ETDP1SMN1; SMN2RAB9APKM
SCHEMBL21485462 0.84 KDM4E (0.56) KDM4ETDP1SMN1; SMN2RAB9APKM
SCHEMBL3299769 0.84 NPC1 (0.50) KDM4ETDP1SMN1; SMN2RAB9APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2236506-A1 Compound having triazine ring structure substituted with group and organic electroluminescent device Hodogaya Chemical Co., Ltd. (JP) 2010-10-06 EP disclosed
EP-2236506-A1 Compound having triazine ring structure substituted with group and organic electroluminescent device Hodogaya Chemical Co., Ltd. (JP) 2010-10-06 EP disclosed
US-20100090588-A1 COMPOUND HAVING TRIAZINE RING STRUCTURE SUBSTITUTED WITH PYRIDYL GROUP AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2010-04-15 US disclosed
US-20100090588-A1 COMPOUND HAVING TRIAZINE RING STRUCTURE SUBSTITUTED WITH PYRIDYL GROUP AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2010-04-15 US disclosed
US-20100090588-A1 COMPOUND HAVING TRIAZINE RING STRUCTURE SUBSTITUTED WITH PYRIDYL GROUP AND ORGANIC ELECTROLUMINESCENT DEVICE HODOGAYA CHEMICAL CO., LTD. (JP) 2010-04-15 US disclosed
EP-2055704-A1 COMPOUND HAVING TRIAZINE RING STRUCTURE SUBSTITUTED WITH PYRIDYL GROUP AND ORGANIC ELECTROLUMINESCENT DEVICE Hodogaya Chemical Co., Ltd. (JP) 2009-05-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100090588-A1 COMPOUND HAVING TRIAZINE RING STRUCTURE SUBSTITUTED WITH PYRIDYL GROUP AND ORGANIC ELECTROLUMINESCENT DEVICE SCO2, OR51E2, NONO KDM4E 756/4885TDP1 2408/4885SMN1; SMN2 4126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.